Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Volume: 379, Issue: 2, Pages: 111 - 121
Published: Jun 3, 2018
Abstract
Background The recurrence score based on the 21-gene breast cancer assay predicts chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it is low; however, there is uncertainty about the benefit of chemotherapy for most patients, who have a midrange score. Methods We performed a prospective trial involving 10,273 women with hormone-receptor–positive, human epidermal growth factor receptor 2...
Paper Details
Title
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Published Date
Jun 3, 2018
Volume
379
Issue
2
Pages
111 - 121
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.